DK1206274T3 - Anvendelse af interleukin-18-inhibitorer til hæmning af tumormetastase - Google Patents

Anvendelse af interleukin-18-inhibitorer til hæmning af tumormetastase

Info

Publication number
DK1206274T3
DK1206274T3 DK00944201T DK00944201T DK1206274T3 DK 1206274 T3 DK1206274 T3 DK 1206274T3 DK 00944201 T DK00944201 T DK 00944201T DK 00944201 T DK00944201 T DK 00944201T DK 1206274 T3 DK1206274 T3 DK 1206274T3
Authority
DK
Denmark
Prior art keywords
interleukin
inhibitors
tumor metastasis
inhibit tumor
inhibit
Prior art date
Application number
DK00944201T
Other languages
English (en)
Inventor
Charles Dinarello
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of DK1206274T3 publication Critical patent/DK1206274T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00944201T 1999-07-22 2000-07-17 Anvendelse af interleukin-18-inhibitorer til hæmning af tumormetastase DK1206274T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (1)

Publication Number Publication Date
DK1206274T3 true DK1206274T3 (da) 2007-08-13

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00944201T DK1206274T3 (da) 1999-07-22 2000-07-17 Anvendelse af interleukin-18-inhibitorer til hæmning af tumormetastase

Country Status (31)

Country Link
US (1) US7741276B2 (da)
EP (1) EP1206274B1 (da)
JP (1) JP4827352B2 (da)
KR (1) KR100682219B1 (da)
CN (1) CN1173736C (da)
AR (1) AR024907A1 (da)
AT (1) ATE363288T1 (da)
AU (1) AU782478B2 (da)
BG (1) BG65800B1 (da)
BR (1) BR0012675A (da)
CA (1) CA2380216C (da)
CY (1) CY1107932T1 (da)
CZ (1) CZ302114B6 (da)
DE (2) DE1206274T1 (da)
DK (1) DK1206274T3 (da)
EA (1) EA005419B1 (da)
EE (1) EE04838B1 (da)
ES (1) ES2186596T3 (da)
HK (1) HK1048248B (da)
HU (1) HU228780B1 (da)
IL (2) IL131047A0 (da)
MX (1) MXPA02000838A (da)
NO (1) NO329827B1 (da)
NZ (1) NZ516535A (da)
PL (1) PL202477B1 (da)
PT (1) PT1206274E (da)
SK (1) SK287522B6 (da)
TR (1) TR200200169T2 (da)
UA (1) UA73745C2 (da)
WO (1) WO2001007480A2 (da)
ZA (1) ZA200200390B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI373343B (en) 2000-02-10 2012-10-01 Abbott Gmbh & Co Kg Antibodies that bind human interleukin-18 and methods of making and using
AU1174402A (en) 2000-10-11 2002-04-22 Viron Therapeutics Inc Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
MXPA05003869A (es) * 2002-10-08 2005-06-22 Ares Trading Sa El uso de citocina capaz de enlazarse a la proteina de union a interleucina-18, y de inhibir la actividad de una segunda citocina.
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
WO2006128908A1 (en) 2005-06-03 2006-12-07 Ares Trading S.A. Production of recombinant il-18 binding protein
EP1891088B1 (en) 2005-06-10 2011-10-19 Ares Trading S.A. Process for the purification of il-18 binding protein
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
WO2023178192A1 (en) 2022-03-15 2023-09-21 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT69922A (en) * 1992-09-02 1995-09-28 Isis Pharmaceuticals Inc Oligonucleotide modification of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
BR9810409A (pt) * 1997-03-18 2000-08-22 Basf Ag Métodos e composições para a modulação de responsividade a corticosteróides
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
CZ302114B6 (cs) 2010-10-20
KR100682219B1 (ko) 2007-02-12
MXPA02000838A (es) 2002-07-30
EA005419B1 (ru) 2005-02-24
HK1048248A1 (en) 2003-03-28
CA2380216A1 (en) 2001-02-01
BRPI0012675B8 (da) 2021-05-25
CZ2002195A3 (cs) 2002-06-12
CN1173736C (zh) 2004-11-03
BG106311A (en) 2002-08-30
SK882002A3 (en) 2002-07-02
HUP0202107A3 (en) 2005-01-28
HUP0202107A2 (en) 2002-10-28
WO2001007480A3 (en) 2001-05-10
PL202477B1 (pl) 2009-06-30
EP1206274A2 (en) 2002-05-22
EP1206274B1 (en) 2007-05-30
ATE363288T1 (de) 2007-06-15
HK1048248B (zh) 2005-04-22
EE04838B1 (et) 2007-06-15
ES2186596T1 (es) 2003-05-16
US20080003216A1 (en) 2008-01-03
IL131047A0 (en) 2001-01-28
HU228780B1 (en) 2013-05-28
BRPI0012675B1 (pt) 2001-02-01
AU782478B2 (en) 2005-08-04
ES2186596T3 (es) 2007-11-16
PT1206274E (pt) 2007-07-06
NO20020153L (no) 2002-03-11
NO329827B1 (no) 2011-01-03
KR20020027493A (ko) 2002-04-13
DE60035049T2 (de) 2007-09-27
TR200200169T2 (tr) 2002-06-21
WO2001007480A2 (en) 2001-02-01
EE200200032A (et) 2003-02-17
NO20020153D0 (no) 2002-01-11
CN1364086A (zh) 2002-08-14
BR0012675A (pt) 2002-04-09
UA73745C2 (en) 2005-09-15
PL353732A1 (en) 2003-12-01
JP2003505472A (ja) 2003-02-12
CA2380216C (en) 2012-01-31
JP4827352B2 (ja) 2011-11-30
AR024907A1 (es) 2002-10-30
US7741276B2 (en) 2010-06-22
BG65800B1 (bg) 2009-12-31
CY1107932T1 (el) 2013-09-04
EA200200189A1 (ru) 2002-12-26
DE60035049D1 (de) 2007-07-12
SK287522B6 (sk) 2011-01-04
AU5843200A (en) 2001-02-13
IL147675A (en) 2009-05-04
ZA200200390B (en) 2003-04-30
DE1206274T1 (de) 2002-11-14
NZ516535A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
EE200300088A (et) Imidasolo-5-üül-2-anilino-pürimidiinid raku proliferatsiooni inhibitsiooni agensitena
DK1315694T3 (da) Inhibitorer af alpha-4-medieret celleadhæsion
ATE524441T1 (de) Vla-4-inhibitoren
NO20015773L (no) Kryssreferanser til relaterte söknader
DK1114051T3 (da) Inhibitorer for p38
DK1183033T3 (da) Pyrrolotriazininhibitorer af kinaser
ATE258918T1 (de) Kristallform alpha des perindopril-tert- butylaminsalzes
DE60127098D1 (de) Inhibitoren der mucin-synthese
DK1307263T3 (da) Hidtil ukendt anvendelse af lipaseinhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
ATE434619T1 (de) Thienodibenzazulenverbindungen als tumornekrosefaktorhemmer
DK1206274T3 (da) Anvendelse af interleukin-18-inhibitorer til hæmning af tumormetastase
DE60123530D1 (de) Raupe aus chemischem Verankerungsklebstoff
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
DE60031450D1 (de) Polymorph v von torasemid
DK1130214T3 (da) Korrosionsinhibitorer
DK1372636T3 (da) Metronomisk dosering af taxaner til hæmning af tumorvækst
SI1206274T1 (sl) Uporaba zaviralcev interlevkina-18 za zaviranje tumorske metastaze
DE60331820D1 (de) Beseitigung von verstopfungen von rohrleitungen
DK1432452T3 (da) Inhibering af STAT-1
AR028052A1 (es) Compuestos fenilo sustituidos inhibidores de la farnesil transferasa
DK1281906T3 (da) Kobling til forbindelse af to ledningsrör
DE60021925D1 (de) Flash-spinnen von polycyclopenten
SE0000713D0 (sv) Methods of synthesis
SE0101231D0 (sv) Novel use of proton pump inhibitors